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ABSTRACT
Objectives To investigate whether artery tertiary
lymphoid organs (ATLOs) are present in giant cell
arteritis (GCA) and that their formation is associated
with the ectopic expression of constitutive lymphoid
tissue-homing chemokines.
Methods Reverse transcriptase PCR,
immunohistochemical and immunoﬂuorescence analysis
were used to determine the presence of ectopic ATLOs in
GCA and the expression of chemokines/chemokine
receptors and cytokines involved in lymphoneogenesis in
the temporal artery samples obtained from 50 patients
with GCA and 30 controls. The presence of lymphatic
conduits, of follicular dendritic cells (FDCs) precursors
and lymphoid tissue inducer cells was also investigated.
Finally, expression of CXCL13, B cell activating factor
(BAFF), a proliferation-inducing ligand (APRIL) and
CCL21 by isolated myoﬁbroblasts was evaluated before
and after stimulation with Toll-like receptors (TLRs)
agonists and cytokines.
Results ATLOs were observed in the media layer of
60% of patients with GCA in close proximity to high
endothelial venules and independently by the age of
patients and the presence of atherosclerosis. ATLO
formation was also accompanied by the expression of
CXCL13, BAFF, a proliferation-inducing ligand (APRIL),
lymphotoxin (LT)-β, interleukin (IL)-17 and IL-7, the
presence of FDC precursors and of lymphoid conduits.
Stimulation of myoﬁbroblasts with TLR agonists and
cytokines resulted in the upregulation of BAFF and
CXCL13.
Conclusions ATLOs occur in the inﬂamed arteries of
patients with GCA possibly representing the immune
sites where immune responses towards unknown arterial
wall-derived antigens may be organised.
INTRODUCTION
Arteries are immunoprivileged sites.1 In advanced
atherosclerotic lesions, however, adventitial lymph-
oid inﬁltrates, sometimes aggregated in lymphoid
follicles (the so-called artery tertiary lymphoid
organs (ATLOs)), occur together with marked
neoangiogenesis and lymphangiogenesis, and with
the extensive induction of high endothelial venules
(HEVs).2 3 The evidence that ATLO formation
increases with age3 may suggest a role of these
structures in disrupting the immune privilege of
normal human arteries. Tertiary lymphoid organs
(TLOs) are often observed also in autoimmune dis-
eases,4 and their induction seems to be dependent
on the aberrant expression of CXCL13, interleukin
(IL)-7 and IL-17.5–7
Giant cell arteritis (GCA), the prototype of large
vessel vasculitis, is a chronic inﬂammatory disease
occurring in the elderly,8 whose pathogenesis is still
elusive. Dendritic cells residing in the vessel wall, in
close proximity to vasa vasorum, seem to be
important in initiating the pathogenic cascade by
recruiting T cells and macrophages to form granu-
lomatous inﬁltrates.9 B cells have been described
mainly in the adventitia of GCA arteries,10 and
recent evidences indicate a disturbed distribution of
IL-6-producing B cells in GCA, suggesting a poten-
tial role of B cell compartment in the pathogenesis
of the disease.11
Although adventitial ectopic lymphoid follicles
have been demonstrated in chronic periaortitis,12
they have been never demonstrated in patients with
GCA and the mechanisms underlying ATLOs for-
mation in inﬂamed vessels not adequately studied.
In this study, we studied the occurrence of ATLO
structures and the expression of cytokines and che-
mokines involved in lymphoneogenesis in patients
with GCA.
PATIENTS AND METHODS
Patients
Fifty patients with GCA (38 females, mean dur-
ation of disease 2±11 months) who fulﬁlled the
American College of Rheumatology classiﬁcation
criteria13 and with biopsy-proven GCA were
included in this study. At the time of temporal
artery biopsy, all the patients were untreated and
prior or current diagnosis of cancer, autoimmune
disease other than GCA or chronic infection was
carefully excluded. Their median age was 69 years
(range 57–82 years) and erythrocyte sedimentation
rate (ESR) was 62 mm/h (range 35–108). Headache
and artery tenderness and/or decreased or absent
temporal artery pulsation were present in 30 out of
50 patients. The baseline inﬂammatory response
was also assessed as described by Hernández-
Rodríguez et al.14 Brieﬂy, four parameters (score
range 0–4) were evaluated at diagnosis: fever,
weight loss, an ESR of 85 mm/h and a haemoglobin
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level of 11.0 gm/dL. Histologically, normal temporal artery
samples from 30 consecutive patients (20 women, 10 men;
median 71 years, range 63–86 years) with suspected GCA but
with negative biopsy results were considered as controls.
Immunohistochemical analysis of GCA biopsy samples
Immunohistochemistry was performed on 5-μm-thick
parafﬁn-embedded sections from temporal artery biopsies
(TABs) and from tonsils (used as positive controls) as previously
described.15 Ten sequential sections were obtained and artery
biopsy specimens were evaluated by two experienced patholo-
gists (AR and AC) with an expertise in vasculitides with no
access to clinical data. The intra-rater agreement and the inter-
rater agreement calculated by the Cohen’s K coefﬁcient for the
two pathologists were 0.84 and 0.79, respectively. The cellular
inﬁltrates and the presence of ATLOs were assessed on the basis
of the histological appearance and conﬁrmed by immunohisto-
chemical staining of sequential sections with monoclonal anti-
bodies to CD3, CD20, CD21 and PNAd (MECA-79) (see
online supplementary table S1) in order to evaluate the presence
of follicular dendritic cells (FDCs) networks, as previously
described.16 Temporal arteries were classiﬁed either as without
ATLOs (when no clear compartmentalisation of T and B cells
could be recognised) or with ATLOs (when inﬂammatory aggre-
gates displayed a well-deﬁned organisation in separated
T-cell-rich and B-cell-rich areas). Expression of lymphoid che-
mokines such as CXCL13, lymphotoxin (LT)-β and B cell acti-
vating factor (BAFF) regulating the recirculation of lymphocytes
and dendritic cells to and within lymphoid structures is one cri-
terion that deﬁnes TLO.4 For this reason, staining for CXCL13,
lymphotoxin (LT)-β and BAFF was performed on sections
sequential to those used to evaluate the presence of ATLOs. In
order to study atherosclerosis, the sections were stained with
Masson’’s trichrome (Sigma-Aldrich). Immunohistochemistry
was performed on 5-μm-thick parafﬁn-embedded sections from
temporal arteries and from tonsils used as positive controls as
previously described.15 A list of primary antibodies is provided
in online supplementary table S1. The primary antibodies were
added and incubated for 1 h at room temperature.
Isotype-matched irrelevant antibodies were used as a negative
control. Following three washes with Tris buffered saline, slides
were incubated for 30 min with peroxidase-conjugated Dako
EnVision polymer. After three further washings, peroxidase
activity was visualised using diaminobenzidine chromogen
(Dako), and slides were lightly counterstained with haematoxy-
lin before dehydration and mounting in DePex (VWR
Figure 1 Artery tertiary lymphoid organ (ATLO) structures in temporal arteries of giant cell arteritis (GCA). Representative images showing the
distribution of CD21 (A), CD19 (B) and CD3 (C) positive cells in temporal arteries without ATLOs. Representative images showing CD21 (D–E), CD19
(F) and CD3 (G) positive cells in GCA temporal arteries with ATLOs. (H) Representative image showing PNAd+ high endothelial venules at the edge
of ATLOs structures. Representative images showing CD21 (I), CD19 ( J) and CD3 (K) positive cells in GCA arteries with ATLOs. (L) Representative
image showing PNAd+ high endothelial venules at the edge of ATLOs structures. (M) Higher number of ATLOs were observed in patients with GCA
with higher systemic inﬂammation. ATLOs were observed independently by the number of inﬁltrating mononuclear cells (N), the presence of
atherosclerosis (O) and/or with the patient’s age (P). (A–D) Original magniﬁcation ×100; (E–L) original magniﬁcation ×250. Data are expressed as
mean (SEM). ATS, atherosclerosis.
2 Ciccia F, et al. Ann Rheum Dis 2016;0:1–9. doi:10.1136/annrheumdis-2016-209217
Basic and translational research
group.bmj.com on November 7, 2016 - Published by http://ard.bmj.com/Downloaded from 
International, Oslo, Norway). The number of immunoreactive
cells was determined by counting positively stained cells on
photomicrographs obtained from three random high-power
microscopic ﬁelds (400× magniﬁcation) under a Leica DM2000
optical microscope using a Leica DFC320 digital camera (Leica,
Rijswijk, The Netherlands). To characterise FDCs, perivascular
precursor sections were incubated with unlabelled antihuman
NG2, CXCL12 and platelet-derived growth factor receptors
(PDGFR)-β and then treated with Fluorescein isothiocyanate
(FITC)-conjugated or rhodamine red-conjugated antirabbit or
antimouse antibodies plus RNasi (200 mg/mL) and counter-
stained using Toto-3 iodide (642/660; Invitrogen). Confocal
analysis was used to acquire ﬂuorescence staining.
Primary cultures of myoﬁbroblasts from human
temporal arteries
Primary cultures of myoﬁbroblasts from TABs were obtained at
the Arcispedale Santa Maria Nuova-IRCCS, Reggio Emilia
(Italy) following the method developed by Lozano et al.17
Brieﬂy, TABs were cut in 1 mm sections, placed in 25 μL matri-
gel drops (BD Biosciences, San Jose, California, USA) and
covered with Dulbecco’s modiﬁed Eagle medium (DMEM) with
high glucose (Euroclone, Italy)+10% fetal bovine serum (FBS),
2 mM glutamine and 50 μg/mL gentamicin. Primary cultures
obtained from TABs showed a myoﬁbroblast phenotype because
they expressed smooth muscle alpha actin and ﬁbroblast activat-
ing protein but did not express or expressed at low levels von
Willebrand factor evaluated by real-time PCR. Primary cultures
were seeded at a density of 40 000 cells per well in six-well
plates in 2 mL DMEM with high glucose+10% fetal bovine
serum (FBS), 2 mM glutamine and 50 μg/mL gentamicin. After
24 h, they were treated with IL-1β (10 ng/mL), IL-6 (10 ng/mL),
interferon (IFN)γ (10 ng/mL) (premium grade from Miltenyi
Biotec), IL-17 (50 ng/mL) (research grade from Miltenyi
Biotec), PolyIC (10 μg/mL) and lipopolysaccharide (LPS, 100 ng/
mL) (from Sigma) in 2 mL DMEM with high glucose+10%
fetal bovine serum (FBS), 2 mM glutamine and 50 μg/mL genta-
micin. Cells were collected after 6 and 24 h of treatment, total
RNA extracted with the miRNeasy micro kit (QIAGEN, Milan,
Italy) and 62.5 ng RNA retro-transcribed with the Takara
reverse transcription kit in a total volume of 20 μL following
the manufacturer’s instruction.
RNA extraction from artery biopsies and quantitative
TaqMan reverse transcriptase PCR
TABs were also stored in RNAlater solution (Applied
Biosystems, Foster City, California, USA). Reverse transcriptase
PCR (RT-PCR) was performed as previously described.15
Master mix and TaqMan gene expression assays for
Glyceraldehyde 3-phosphate dehydrogenase (GAPDH) control
and target genes were obtained from Applied Biosystems (Foster
City). A list of primers is provided in online supplementary
table S2.
Statistical analysis
Statistical analysis of quantitative variables was performed using
the Mann–Whitney rank-sum test. Pearson’s correlation analysis
was used to quantify the expression associations between the
genes of interest. p Values <0.05 were considered signiﬁcant.
Figure 2 Artery tertiary lymphoid organs (ATLOs) are present in the media layer of giant cell arteries. ATLO structures are organised in separate
T cell areas, B cell follicles and a network of follicular dendritic cells (FDCs). FDC precursors are present in close proximity of vasa vasorum and may
participate in the formation of ATLO structures. Newly formed lymphatic conduits may serve to transport chemokines and antigens. HEV, high
endothelial venules.
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RESULTS
ATLOs are present in GCA temporal arteries and correlate
with systemic inﬂammatory responses
All the patients enrolled had a biopsy-proven GCA with tem-
poral transmural inﬂammation. In order to detect ATLOs,
sequential temporal artery samples from patients and controls
were stained with anti-CD3, anti-CD20 and anti-CD21 anti-
bodies. Evidence of diffuse T cells inﬁltration without the con-
comitant B cells presence was observed in 20 of 50 patients
with GCA (ﬁgure 1A–C). In the remaining 30 patients with
GCA, B cells were invariably associated with a deﬁned T cell/B
cell segregation surrounding a central area consisting of CD21+
cells (FDCs) (ﬁgure 1D–G,I–K). Twenty-ﬁve of these arteries
(83%) displayed only one area of T/B/FDC compartmentalisa-
tion, the remaining ﬁve displaying up to two areas of T/B/FDC
compartmentalisation. ATLOs were never observed in control
temporal arteries. ATLOs were invariably observed near to vas-
cular structure morphological resembling HEVs (ﬁgures 1E–G,
I–L asterisks and 2) exclusively located in the context of media
layer. We next evaluated whether such vessels express PNAd,
the addressin system typical of secondary lymphoid organs. As
shown in ﬁgures 1H,L and 2, PNAd+ HEVs were observed at
the edge of lymphoid aggregates, in all the patients with GCA
displaying ATLOs. The number of ATLOs was signiﬁcantly cor-
related with parameters of systemic inﬂammatory response
(ﬁgure 1M) but not with duration of symptoms prior to biopsy
and speciﬁc GCA features such as jaw claudication, headache,
scalp tenderness and permanent visual loss (data not shown).
We also investigated whether the degree of arterial inﬂamma-
tion, evaluated by counting inﬁltrating inﬂammatory mono-
nuclear cells, the presence of giant cells and intimal disruption,
was the main factor associated with ATLOs. No signiﬁcant
differences in the numbers of inﬁltrating inﬂammatory cells,
presence of giant cells and intimal disruption between non-
segregated versus segregated arteries (ﬁgure 1N) were found,
indicating that the number of inﬂammatory cells alone and the
Figure 3 Chemokine expression in giant cell arteritis (GCA) temporal arteries. Relative mRNA levels of CXCL13 (A), CXCR5 (B), lymphotoxin (LT)-β
(C), B cell activating factor (BAFF) (D), a proliferation-inducing ligand (APRIL) (E), interleukin (IL)-7 (F), IL-7R (G) and IL-17 (H) were assessed by
quantitative reverse transcriptase PCR in GCA artery samples obtained from patients with GCA and controls. Data are expressed as individual data
points (mean). ATLOs, artery tertiary lymphoid organs; HC, healthy controls.
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presence of giant cells are not sufﬁcient to determine the pro-
gression of lymphoid organisation. We also evaluated whether
the presence of ATLOs was associated with atherosclerotic
lesions. Presence of ATLOs was associated with the presence of
atheromatous plaques in the arterial tunica intima in only 2 of
30 patients (ﬁgure 1O). Finally, since ATLO formation appears to
be related with ageing, the occurrence of ATLOs was correlated
with the age of patients with GCA. ATLOs were similarly observed
in patients with GCA independently by the age (ﬁgure 1P).
Collectively these data indicated that ATLOs formation occurs in a
signiﬁcant proportion of GCA arteries independently by the inten-
sity of tissue inﬂammation, age and the presence of atherosclerosis.
Differential expression of chemokines and chemokine
receptors and cytokines involved in lymphoneogenesis
in GCA arteries
Since the occurrence of ATLOs in patients with GCA, we next
evaluated the expression levels of different chemokines and che-
mokine receptors and cytokines involved in lymphoneogenesis:
CXCL13, CXCR5, CCL21, CCR7, lymphotoxin (LT)-β, BAFF, a
proliferation-inducing ligand (APRIL), IL-7 and IL-17. As shown
in ﬁgure 3, signiﬁcant overexpression of CXCL13 (ﬁgure 3A),
CXCR5 (ﬁgure 3B), lymphotoxin (LT)-β (ﬁgure 3C), BAFF (ﬁgure
3D), a proliferation-inducing ligand (APRIL) (ﬁgure 3E), IL-7
(ﬁgure 3F), IL-7R (ﬁgure 3G) and IL-17 (ﬁgure 3H) was observed
in ATLOs+ compared with ATLOs− arteries and controls. IL-17
and IL-7 expression was signiﬁcantly correlated with the levels of
CXCL13 only in ATLO-positive arteries (IL-7: r2=0.36,
p=0.0001; IL-17: r2=0.13, p=0.02). Conversely, no signiﬁcant
increase of CCL21 and its receptor CCR7 was observed in all the
inﬂamed arteries independently by the presence of ATLOs (data
not shown). The expression of CXCL13, BAFF and lymphotoxin
(LT)-β was next studied by immunohistochemistry (IHC). The
presence of ATLOs in GCA arteries was associated with CXCL13
(ﬁgure 4A–D), BAFF (ﬁgure 4E–H) and lymphotoxin (LT)-β
expression (ﬁgure 4I–L). In particular, immunohistochemistry
(IHC) staining showed a strong expression of CXCL13 and BAFF
within inﬁltrating cells, vascular smooth muscle cells and HEVs.
Interestingly, lymphotoxin (LT)-β was signiﬁcantly overexpressed
by lymphoid cells in both arteries with (ﬁgure 4I) and without
(ﬁgure 4J) ATLOs. Since the localisation of ATLOs in the media
layer and the strong expression of CXCL13 and BAFF in the
context of vascular smooth muscle cells, we next evaluated their
expression in primary cultures of myoﬁbroblasts obtained from
temporal arteries of ﬁve GCA and three control arteries. The
expression of CXCL13, BAFF and lymphotoxin (LT)-β in myoﬁ-
broblasts was assessed by RT-PCR and demonstrated in GCA a sig-
niﬁcant overexpression of CXCL13 (see online supplementary
ﬁgure S1A), CXCR5 (see online supplementary ﬁgure S1B), BAFF
(see online supplementary ﬁgure S1C) but also of lymphotoxin
Figure 4 CXCL13, B cell activating factor (BAFF) and lymphotoxin (LT)-β expression in giant cell arteritis (GCA) temporal arteries. Representative
microphotographs showing CXCL13 expression in arteries obtained from patients with GCA with artery tertiary lymphoid organs (ATLOs) (A) and
normal controls (B). (C) Representative image showing GCA arteries stained with isotype control antibody. (D) Semiquantitative evaluation of
CXCL13-positive cells. Representative microphotographs showing BAFF expression in arteries obtained from GCA patients with ATLOs (E) and normal
controls (F). (G) Representative image showing GCA arteries stained with isotype control antibody. (H) Semiquantitative evaluation of BAFF-positive
cells. Representative microphotographs showing lymphotoxin (LT)-β expression in arteries obtained from patients with GCA with ATLOs (I), without
ATLO ( J) and control (K). Inset in (K) shows GCA arteries stained with isotype control antibody. (L) Semiquantitative evaluation of lymphotoxin
(LT)-β-positive cells. Data are expressed as individual data points (mean).
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(LT)-β (see online supplementary ﬁgure S1D). These data seem to
indicate that stromal cells of GCA arteries are equipped with
pro-inﬂammatory chemokines involved in lymphoneogenesis.
In vitro stimulation of primary cultures from temporal
arteries with TLR agonists and cytokines modulates CXCL13,
BAFF, a proliferation-inducing ligand (APRIL) and CCL21
production
Since the increased expression in GCA myoﬁbroblasts of chemo-
kines involved in lymphoneogenesis, we next evaluated whether
the expression of CXCL13, BAFF, a proliferation-inducing
ligand (APRIL) and CCL21 may be modulated by Toll-like
receptor (TLR) agonists and cytokines. IL-17, IL-6, poly-IC and
LPS stimulation of primary cultures of myoﬁbroblasts resulted
in a signiﬁcant upregulation of CXCL13 (ﬁgure 5A) and BAFF
(ﬁgure 5B). BAFF was signiﬁcantly upregulated also by IFNγ,
whereas a proliferation-inducing ligand (APRIL) overexpression
was induced only after IL-6 stimulation (ﬁgure 5C). Finally,
CCL21 was upregulated by IL-1β, IFNγ, IL-17 and IL-6 but not
by TLR agonists (ﬁgure 5D). These ﬁndings demonstrate a ﬁne
and differential regulation of different chemokines in myoﬁbro-
blasts of GCA.
Lymphatic conduits are present in GCA arteries with ATLOs
and connect ATLOs with muscular layer
Lymphatic conduits are the main way used by antigens to enter
in lymphoid structures, and their presence has been demon-
strated in atherosclerotic arteries forming a reticular meshwork
of ﬁbres enfolded by podoplanin-expressing ﬁbroblastic reticular
cells.3 In order to evaluate the presence of lymphatic conduits
in GCA arteries, staining with 8.1.1 (podoplanin/gp38) was per-
formed. Intense podoplanin staining was consistently detected in
the areas where ATLOs were present (ﬁgures 2 and 6A) as well as
on lymphatic vessels outside the germinal centre (ﬁgure 6B), but
not in control arteries.
FDC perivascular precursors are expanded in GCA arteries
FDCs are essential in the development and maintenance of
lymphoid follicles.18 It has been recently demonstrated that
FDCs derive from ubiquitous perivascular precursors and that
they are dependent for their proliferation by lymphotoxin
(LT)-αβ-producing lymphoid tissue inducer (lymphotoxin (LT)i)
cells.19 As shown in ﬁgures 2 and 7, FDC precursors, identiﬁed as
CXCL13+/NG2+/platelet-derived growth factor receptors
(PDGFR)b+ cells, were present in the majority of inﬂamed arteries
being the highest number observed in the presence of ATLO.
DISCUSSION
In chronic inﬂammatory diseases, primary T cell responses are
thought to be initiated in secondary lymphoid organ (SLOs) and
in TLOs, unencapsulated lymphoid aggregates occurring post-
natally at undetermined sites in response to non-resolving
inﬂammation.4 Adventitial lymphoid inﬁltrates, sometimes
aggregated in lymphoid follicles (so-called ATLOs), have been
demonstrated to increase with age and to be associated with the
presence of atherosclerosis.3
GCA is the prototype of large vessel vasculitis and has been
mainly considered to be driven by a cell-mediated reaction
involving activated macrophages, multinucleate giant cells and T
Figure 5 Chemokine modulation in primary cultures from temporal arteries. Myoﬁbroblast-like cultures were obtained from temporal arteries of
patients with giant cell arteritis and controls and cultured in the presence of different stimuli. Modulation of chemokines expression was assessed by
reverse transcriptase PCR. (A) CXCL13 modulation by different pro-inﬂammatory cytokines and Toll-like receptor (TLR) agonists. (B) B cell activating
factor (BAFF) modulation by different pro-inﬂammatory cytokines and TLR agonists. (C) a proliferation-inducing ligand (APRIL) modulation by
different pro-inﬂammatory cytokines and TLR agonists. (D) CCL21 modulation by different pro-inﬂammatory cytokines and TLR agonists. IL,
interleukin; LPS, lipopolysaccharide; RPMI, Roswell Park Memorial Institute medium.
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lymphocytes.9 The presence of ectopic lymphoid organs has
been demonstrated in chronic periaortitis12 but not in GCA and
the microanatomic association between expression of cytokines
and chemokines involved in lymphoneogenesis and the acquisi-
tion of lymphoid features in inﬂamed arteries not yet studied.
In this study, we demonstrated for the ﬁrst time, to our
knowledge, that distinct ATLOs structures, including placed B
cell aggregates with a FDC network, loosely surrounded by T
cells, and the extensive formation of HEV, occur in a signiﬁcant
proportion of patients with GCA (an image that summarises the
structure of ATLOs in GCA arteries is shown in ﬁgure 2). HEVs
are specialised postcapillary venous characterised by almost
cuboidal endothelial cells that support high levels of lymphocyte
extravasation from the blood. HEV-like vessels have been
demonstrated in chronically inﬂamed non-lymphoid tissues, and
their differentiation appears to be under the control of the local
tissue environment.20 In GCA, neo-angiogenesis occurs in the
media layer where HEVs are mainly observed, indicating that
cytokines/chemokines released by vascular smooth muscle cells
(VSMCs) may be essential in determining HEV differentiation.
The spatial distribution of HEV in GCA may be responsible for
the peculiar location of GCA lymphoid aggregates that, differ-
ently from ‘classic’ ATLOs, were mainly observed in the media
layer of inﬂamed temporal arteries. ATLOs were not associated
with the age of patients and/or with the occurrence of athero-
sclerotic lesions, and were also independent by the degree of
arterial inﬂammation. In addition, newly formed lymphatic con-
duits establish a network connecting ATLOs to the medial vas-
cular smooth muscle cells (VSMC). This conduit network has
been demonstrated to serve as channels for the transport of
soluble antigen and chemokines/cytokines between the activated
vascular smooth muscle cells (VSMCs) and ATLOs.19 21 22
FDCs are essential in engaging B cells in the SLOs and TLOs.
FDCs have been demonstrated to emerge from ubiquitous peri-
vascular precursors also in non-lymphoid organs.23 FDCs gener-
ated de novo in TLO seem to arise from these progenitor cells
when exposed to the appropriate environment. Herein we
demonstrated that perivascular FDC precursors are present in
the media layer of GCA arteries with ATLOs, indicating that a
speciﬁc chemokine and cytokine environment may induce their
differentiation in mature FDC and the appearance of tertiary
lymphoid structures.
CXCL13 and CCL21, produced by vascular smooth cells,
have been demonstrated to be instrumental in maintaining FDC
networks in mouse arteries, and IL-7/IL-17 axis has been also
demonstrated to be required for the organisation of ectopic
lymphoid structures.3 24 25 In particular, CXCL13-attracted B
cells, which are home to the follicles, are the source of lympho-
toxin (LT)-α1β2,25 which is critical for the generation and main-
tenance of established follicles. Analysis of tissue expression of
cytokines, chemokines and their receptors in ATLOs-positive
GCA arteries demonstrated a clear increased expression of
IL-17 and IL-7, correlated with that of CXCL13, and of their
receptor IL-7R and CXCR5. Interestingly, BAFF, a proliferation-
inducing ligand (APRIL) and lymphotoxin (LT)-β were also
upregulated, whereas no signiﬁcant overexpression of CCL21
and of its receptor CCR7 was observed. lymphotoxin (LT)-β
was essentially expressed among inﬁltrating lymphoid cells.
Conversely, CXCL13 and BAFF were predominantly expressed
among vascular smooth muscle cells (VSMCs) and endothelial
Figure 6 Ectopic lymphoid conduits are present in giant cell arteritis (GCA) temporal arteries. Representative microphotographs showing
podoplanin+ lymphoid vessels in GCA arteries in the context of artery tertiary lymphoid organ (ATLO) structures (A) and outside of ATLOs (B).
(C) Representative microphotographs showing podoplanin staining in normal arteries. (D) Representative microphotographs showing GCA arteries
stained with isotype control antibody.
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cells of HEV. Microvascular endothelial cells have been demon-
strated to produce BAFF and a proliferation-inducing ligand
(APRIL) constituting a key component of the neoplastic stroma
by cross-talking with neoplastic B cells.26 Our ﬁndings indicate
that HEV cells may be also essential in establishing an intimate
cross-talk with artery inﬁltrating B cells through the production
of B-cell-activating chemokines.
Immune-stromal communications between T cells and myoin-
timal cells have been previously demonstrated in GCA.9 In this
work, we provide the evidence that primary human temporal
artery-derived myointimal cells may also interact with B cells via
the production of B-cell-attracting chemokines in GCA. We
demonstrated that primary cultures of myoﬁbroblasts obtained
from temporal arteries constitutively express large amounts of
CXCL13 and BAFF, and that expression of CXCL13, BAFF, a
proliferation-inducing ligand (APRIL) and CCL21 is differen-
tially regulated by TLR agonists and cytokines. TLR3 and TLR4
stimulation in fact induced in such primary cultures a strong
and rapid upregulation of both BAFF and CXCL13 but not of
CCL21 and a proliferation-inducing ligand (APRIL). Conversely,
stimulation with different pro-inﬂammatory cytokines such as
IL-1β, IL-6, IL-17 and IFNγ, involved in the pathogenesis of
GCA, differentially resulted in the signiﬁcant upregulation of
BAFF, CXCL13, CCL21 and in a less manner of a proliferation-
inducing ligand (APRIL). TLR3 and TLR4 are members of the
TLR family recognising pathogen-associated molecular patterns
expressed on infectious agents, and mediating the production of
cytokines of innate immunity.27 Vascular smooth muscle cells
have been demonstrated to express TLR328 and TLR4,29 and
their stimulation, potentially triggered by infective agents, might
mediate the early release of CXCL13 and BAFF, thus attracting
lymphotoxin (LT)i cells and inducing their initial clustering.30
In summary, in this study we report that (1) ATLOs structures
occur in GCA arteries; (2) IL-7 and IL-17 are associated with
the presence of ATLOs structures; (3) ectopic expression of
CXCL13, BAFF and lymphotoxin (LT)-β is associated with the
presence of ATLOs; (4) BAFF and CXCL13 are induced by
TLR3 and TLR4 ligands; and (5) BAFF and CXCL13 are
induced by pro-inﬂammatory cytokines. Further studies are
required to better clarify the clinical relevance of ATLOs in
GCA.
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